STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2021

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

SCHEDULE OF STOCK-BASED COMPENSATION

Stock-based compensation, including restricted stock awards, stock options and warrants is included in the unaudited condensed consolidated statement of operations as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Research and development	$	18,786	$	15,873	$	62,980	$	47,618
Sales and marketing		60,771		28,991		184,853		101,695
General and administrative		3,580,935		122,905		6,750,153		325,862
Total	$	3,660,492	$	167,769	$	6,997,986	$	475,175

SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following table reflects the stock option activity:

	Number of Shares			Weighted Average Exercise Price		Contractual Life (Years)
Outstanding at December 31, 2020		1,920,269		$	4.40		8.66
Exercised		(555,004	)	$	2.72
Forfeitures		(2,500	)	$	2.52
Outstanding at September 30, 2021		1,362,765		$	5.09		8.31

SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

The Company uses the following inputs when valuing stock-based awards.

	Nine Months Ended September 30,
	2021		2020
Expected life (years)		N/A		5.0
Risk-free interest rate		N/A		0.24	%
Expected volatility		N/A		89.96	%
Total grant date fair value	$	N/A	$	2.30-3.63

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following table reflects the restricted stock activity:

	Number of Shares			Weighted Average Grant Price
Outstanding at December 31, 2020		1,072,503		$	5.30
Granted		622,000		$	3.91
Vested		(1,158,891	)	$	5.64
Forfeitures		(42,612	)	$	3.17
Outstanding at September 30, 2021		493,000		$	2.93